Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

89Bio Inc (ETNB)

89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
89bio, Inc. Presents New Data from Phase 2b ENLIVEN Trial of Pegozafermin for Advanced MASH at AASLD 2024 Quiver Quantitative, Inc. - Fri Nov 15, 5:20PM CST

89bio presented new Phase 2b trial data on pegozafermin for treating advanced MASH, highlighting potential benefits in fibrosis reversal.Quiver AI Summary89bio, Inc. announced new analyses from its Phase...

ETNB : 8.38 (+5.01%)
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 GlobeNewswire - Fri Nov 15, 7:05AM CST

ETNB : 8.38 (+5.01%)
89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire - Tue Nov 12, 10:58PM CST

ETNB : 8.38 (+5.01%)
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire - Tue Nov 12, 3:01PM CST

ETNB : 8.38 (+5.01%)
89bio Reports Third Quarter 2024 Financial Results and Corporate Updates GlobeNewswire - Thu Nov 7, 3:05PM CST

ETNB : 8.38 (+5.01%)
89bio to Participate in the UBS Global Healthcare Conference GlobeNewswire - Tue Nov 5, 3:05PM CST

ETNB : 8.38 (+5.01%)
89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024 GlobeNewswire - Tue Oct 15, 7:30AM CDT

ETNB : 8.38 (+5.01%)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Oct 11, 3:05PM CDT

ETNB : 8.38 (+5.01%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? Motley Fool - Sun Mar 17, 4:50AM CDT

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 2.72 (-3.37%)
GLMD : 2.80 (-5.41%)
VKTX : 53.55 (+3.72%)
ETNB : 8.38 (+5.01%)
IVA : 2.66 (-2.92%)
SGMT : 4.50 (-0.44%)
TERN : 5.46 (-4.41%)
NVO : 103.88 (+1.22%)
IQV : 197.99 (+0.20%)
MDGL : 329.24 (+3.83%)
Why Shares of 89bio Plummeted on Tuesday Motley Fool - Tue Oct 10, 2023

So-so trial data for a competitor's NASH therapy candidate that is similar to 89bio's candidate spooked investors.

AKRO : 31.20 (+1.84%)
ETNB : 8.38 (+5.01%)

Barchart Exclusives

1 'Strong Buy' AI Server Stock to Buy Instead of Super Micro Computer Barchart - 25 minutes ago
Down 25% from record highs, Dell Technologies is positioned to benefit from the AI megatrend, making it a top stock to own, compared to Super Micro Computer. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot